New Covid-19 Vaccine, Myocarditis Claims From Questionable Abstract In American Heart Association Journal

Twitter has added a warning to anyone clicking on the link to this abstract.
Source: Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Social Media /social-media business pharma Source Type: news

Related Links:

Conditions:   Myopericarditis;   Myocarditis;   Vaccination; Complications;   COVID-19 Pandemic;   SARS-CoV2 Infection Intervention:   Biological: Pfizer-BioNTech mRNA COVID-19 vaccination Sponsors:   Rigshospitalet, Denmark;   Innovation Fund Denmark;   Ministry of Education, Denmark Recruiting
Source: - Category: Research Source Type: clinical trials
Vaccine. 2021 Dec 24:S0264-410X(21)01654-6. doi: 10.1016/j.vaccine.2021.12.044. Online ahead of print.ABSTRACTIn South Korea, all 12th grade students (highs school seniors) were offered BNT162b2 vaccine starting July 19, 2021; while 10th-11th grade students were not eligible. We conducted a nationwide retrospective cohort study by to determine the safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents against SARS-CoV-2 infection. Among 444,313 persons who received the first dose of vaccine, reporting rate for myocarditis and/or pericarditis was 1.8 per 100,000 (95% C.I. 0.8-3.5) among first-dose recipie...
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research
AbstractIn this review, we provide a brief description of recently published articles addressing topics relevant to pediatric cardiologists. Our hope is to provide a summary of the latest articles published recently in other journals in our field. The articles address the extracardiac anomalies in fetuses with congenital heart disease, post COVID-19 vaccination myocarditis, the use of cardiac magnetic resonance after the Fontan operation, congenitally corrected transposition in adults, robitically assisted congenital heart surgery and the increased risk of congenital heart surgery in patients receiving tracheal surgery dur...
Source: Pediatric Cardiology - Category: Cardiology Source Type: research
Should myocarditis be a concern as mRNA-based COVID-19 vaccines are authorized in ever-younger age groups? The rare complication's epidemiology and insights about its mechanism hold clues.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
The U.S. is urging that everyone 12 and older get a COVID-19 booster as soon as they’re eligible, to help fight back the hugely contagious omicron mutant that’s ripping through the country. Boosters already were encouraged for all Americans 16 and older, but Wednesday the Centers for Disease Control and Prevention endorsed an extra Pfizer shot for younger teens—those 12 to 15—and strengthened its recommendation that 16- and 17-year-olds get it, too. “It is critical that we protect our children and teens from COVID-19 infection and the complications of severe disease,” Dr. Rochelle Walens...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 wire Source Type: news
Young children who get the Pfizer-BioNTech COVID-19 vaccine often have mild side effects, but serious reactions are rare, according to a recent government analysis on vaccine safety in children ages 5 to 11. The data come from the Vaccine Adverse Event Reporting System (VAERS), a large vaccine safety surveillance system maintained by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA), and v-safe, the CDC’s smartphone-based reporting system specifically for COVID-19 vaccine reactions. “After over 8 million COVID-19 vaccinations in this age group, we found t...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
CONCLUSION: Until we obtain a more precise explanation of the mechanism of myocarditis after vaccination with the anti-COVID-19 vaccine, all symptoms suggesting myocarditis should be systematically monitored during the first 7 days after vaccination.PMID:34980975 | PMC:PMC8716151 | DOI:10.1016/j.amsu.2021.103210
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research
Purpose of review Cardiovascular involvement in coronavirus disease 2019 (COVID-19) is relatively common and portends an increased risk of morbidity and mortality. Manifestations of myocardial injury may exhibit significant overlap and result in diagnostic uncertainty. This review will summarize recent literature around cardiovascular complications of COVID-19. Recent findings Venous thromboembolism, atrial fibrillation, and type II myocardial infarction are observed commonly in COVID-19, while severe acute respiratory syndrome coronavirus 2 viral myocarditis remains quite rare. Although infrequent, COVID-19 vac...
Source: Current Opinion in Anaesthesiology - Category: Anesthesiology Tags: CARDIOVASCULAR ANESTHESIA: Edited by Nirvik Pal Source Type: research
ConclusionThese extremely rare vaccine-related adverse events are much less common than the risk of myocarditis and other lethal complications from COVID-19 infection. The benefits of vaccination far exceed the risks of COVID-19 infection.
Source: Journal of Clinical Immunology - Category: Allergy & Immunology Source Type: research
Circ J. 2021 Dec 25. doi: 10.1253/circj.CJ-21-0935. Online ahead of print.NO ABSTRACTPMID:34955479 | DOI:10.1253/circj.CJ-21-0935
Source: Circulation Journal - Category: Cardiology Authors: Source Type: research
More News: Cardiology | COVID-19 | Heart | Myocarditis | Pharmaceuticals | Vaccines | Warnings